HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined blockade of AMPA and NMDA receptors in the brain of rats prevents pentylenetetrazole-induced clonic and tonic-clonic seizures without ataxia.

Abstract
Intramuscular injection of selective NMDA receptor antagonists memantine and arcaine 4-fold decreased the incidence of pentylenetetrazole-induced generalized tonic-clonic seizures in rats, while the incidence of clonic seizures decreased by 1.2-1.3 times. Memantine and arcaine are characterized by low therapeutic index, i.e. induced ataxia in rats in doses exceeding the effective anticonvulsant dose by only 3.5-10 times. Intramuscular injection of IEM-1913 (combined blockade of NMDA and AMPA receptors in the brain) decreased the incidence of pentylenetetrazole-induced clonic and tonic-clonic seizures in rats by 4-8 times. The therapeutic index of IEM-1913 surpassed that of memantine and arcaine by 200-600 times.
AuthorsV E Gmiro, S E Serdyuk
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 145 Issue 6 Pg. 728-30 (Jun 2008) ISSN: 0007-4888 [Print] United States
PMID19110562 (Publication Type: Journal Article)
Chemical References
  • Biguanides
  • Receptors, AMPA
  • Receptors, N-Methyl-D-Aspartate
  • arcaine
  • Memantine
  • Pentylenetetrazole
Topics
  • Animals
  • Ataxia (chemically induced)
  • Biguanides (pharmacology, therapeutic use)
  • Drug Synergism
  • Drug Therapy, Combination
  • Epilepsy, Tonic-Clonic (chemically induced, complications, prevention & control)
  • Male
  • Memantine (pharmacology, therapeutic use)
  • Pentylenetetrazole
  • Rats
  • Receptors, AMPA (antagonists & inhibitors)
  • Receptors, N-Methyl-D-Aspartate (antagonists & inhibitors)
  • Seizures (chemically induced, complications, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: